Condition
Uterine Leiomyomata
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00005095Recruiting
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
NCT01463462Completed
Electronic Catheter Stethoscope
NCT01069094Phase 1CompletedPrimary
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
NCT00837161Phase 1Completed
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
Showing all 4 trials